Funding entities and research funded

2013-2016

"Funding to establish stable structures in the area of biomedicine and health science – Addictive Disorders Network"

Funding entity: National Institute of Health Carlos III
Reference Number: RD12/00028/0015

2013-2014

"Brain and plasma epigenetic markers for alcohol addiction and its cognitive deficits"

Funding entity: The European Foundation for Alcohol Research
Reference Number: EA 12 21

2011-2014

“Integration of the endocannabinoid system and alpha-synuclein protein: pharmacological characterization of alcohol and cocaine addiction”

Funding entity: Spanish Ministry of Economy and Competitiveness
Reference Number: SAF2011-26818

2011-2014

“Study for the evaluation of drug addiction prevention programs in Madrid public schools”

Funding entity: Department of Health Anti-drug Agency. Community of Madrid
Reference Number: Art83. 2011-2014

2009-2011

“Co-abuse of alcohol and cocaine: neuropsychological exploration based on gene expression using voluntary self-administration animal models for the development of new dual therapeutic and preventive targets."

Funding entity: National Strategy on drugs – Spanish Ministry of Health and Consumer Affairs
Reference Number: PR61/08-16415

2009-2011

“Study and functional identification of genes using animal behavioural models of self-administered drugs of abuse”

Funding entity: Spanish Ministry of Science and Innovation
Reference Number: SAF2008-03763

2008-2012

“Funding to establish stable structures in the area of biomedicine and health science – Addictive Disorders Network”

Funding entity: National Institute of Health Carlos III & Spanish Ministry of Health and Consumer Affairs
Reference Number: RD06/0001/0011

2007-2010

Research Group “Addiction Psychopharmacology” Complutense University

Funding entity: Complutense University and the Community of Madrid/Banco Santander
Reference Number: GR69/06 -940157

2007-2009

“Grant for the development of Scientific-Technological Projects”

Funding entity: European Regional Develop Fund, European Union
Reference Number: UCMA06-33-059

2007-2010

“Study for the evaluation of drug addiction prevention programs in Madrid public schools”

Funding entity: Department of Health Anti-drug Agency. Community of Madrid
Reference Number: Art83. 2011-2014

Participation in other research projects or as co-principal investigator

2005-2008

“Long-lasting alcohol consumption in the relapse-like phase after drug exposure during alcohol deprivation periods in rats”

Funding entity: Ministry of Education and Science
Reference Number: SAF2005-04926

2005-2008

“Study of neurochemical and psychobiological parameters of long-lasting alcohol consumption in the relapse-like phase caused by several drugs of abuse (cannabinoids, MDMA and nicotine) in rats”

Funding entity: National Strategy on drugs – Spanish Ministry of Health and Consumer Affairs
Reference Number: PR48/05-14117

2005

“Role of the endocannabinoid system in nicotine relapse after chronic exposure to alcohol and cannabinoids”

Funding entity: Community of Madrid
Reference Number: GR/SAL/0541/2004

2002-2004

“Role of the endogenous cannabinoid system in ethanol and nicotine addiction: implications for the treatment of drug addiction”

Funding entity: Research Directorate General. Quality of Life and Life Management Resources Program – The European Commission Community Research Program (VI Framework Program)
Reference Number: QL64-CT-2001-01691

2002-2004

“Participation of the endocannabinoid system in alcohol and opioid-addicted behaviour in rats”

Funding entity: Ministry of Science and Technology
Reference Number: BFI2001-2079-C02-01

2002-2003

“Psychopharmacological study of cocaine-addicted patients”

Funding entity: Human Project
Reference Number: Art83. PH-UCM 2002-03